Boston Scientific Corp. on Tuesday mentioned it had agreed to purchase British health-care agency BTG PLC for £3.Three billion ($4.24 billion), bolstering its presence within the rising area of interventional medication.

READ  Police on the lookout for automotive that fled after putting, severely injuring pedestrian

The Marlborough, Mass.-based medical units maker mentioned it will pay 840 pence a share in money for BTG, a 37% premium to the U.Okay.-listed firm’s closing value Monday. BTG’s shares jumped 33% on the information.

READ  Report on Volkswagen’s Modifications Since Emissions Scandal Cites Lack of Transparency



Please enter your comment!
Please enter your name here